Login to Your Account

Other News To Note

Friday, December 9, 2011
• Bionovo Inc., of Emeryville, Calif., published preclinical data showing use of either estrogen or Bionovo's botanically derived tissue selective estrogen receptor modulators resulted in weight loss in mouse models of postmenopausal obesity. However, Bionovo's compounds did not adversely affect the breast or uterus, while estrogen stimulated proliferation of cells in the mammary gland and uterus. The data were published in the Journal of the Public Library of Science One.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription